Answer
IXCHIQ contains live-attenuated chikungunya virus (CHIKV) of the ECSA/IOL genotype and elicits neutralising antibodies against CHIKV, although the exact mechanism of protection against infection and/or disease has not been determined.
Sources for this answer
- IXCHIQ Chikungunya vaccine (live)Valneva UK Limited · emc · SmPC §5.1 Pharmacodynamic properties · Version 1Document updated
Sources checked